العودة إلى لوحة التحكم / Back to Dashboard

Knowledge, Attitudes, and Preventive Practices Toward Diabetes Complications Among Diabetic Patients at the Diabetes Center in Dongola, Sudan 2026

ETH-20260112-0092 تاريخ التقديم: Jan 12, 2026 / Submitted: Jan 12, 2026
قيمة الرسوم / Payment Amount
0.00 SDG
نوع البحث / Research Type
بكالوريوس / Bachelor's
فترة الدراسة / Study Period
Dec 30, 2025 - Feb 28, 2026
Approved
السودان - الولاية الشمالية
وزارة الصحة
الادارة العامة للتخطيط والتنمية الصحية
إدارة البحوث
لجنة الموافقة الأخلاقية
طلب الموافقة الأخلاقية - Ethical Approval Request Form
---
Ethical Approval Request Form
General Administration for Planning and Health Development
Research Department
Ethical Approval Committee
---
رقم التسلسل
Serial Number
SER-20260112-0092
رقم الطلب
Request Number
ETH-20260112-0092
تاريخ تقديم الطلب
Date of Submission
2026-01-12

القسم الأول: معلومات الباحث / Principal Investigator Information

1. الاسم الكامل للباحث الرئيسي
Principal Investigator Full Name
سمية فياض مدني محمد
2. الجهة التي ينتمي إليها
Affiliation Type
-
3. الوظيفة / اللقب العلمي
Job Title/Academic Degree
-
4. البريد الإلكتروني
Email Address
Semsema9720@gmail.com
5. رقم الهاتف
Phone Number
0929120457
المشرف / Supervisor
الاسم الكامل / Full Name
-Dr.Rehab Ahmed Hussien Fadlallah
البريد الإلكتروني / Email
rehabahmed2003@gmail.com
الوظيفة / اللقب العلمي / Job Title
MBBS, CBIC, Diploma TB epidemiology and Control, MD Community Medicine
رقم الهاتف / Phone
+249 91 282 4734
القسم / المؤسسة / Department
Medicine community

القسم الثاني: تفاصيل الدراسة البحثية / Research Study Details

7. عنوان الدراسة
Study Title
Knowledge, Attitudes, and Preventive Practices Toward Diabetes Complications Among Diabetic Patients at the Diabetes Center in Dongola, Sudan 2026
8. نوع البحث (يرجى التحديد)
Type of Research (Please select)
☐دكتوراه / PhD
☐ماجستير / Master's
☑بكالوريوس / Bachelor's
☐دبلوم عالي / Postgraduate Diploma
☐دبلوم وسيط / Intermediate Diploma
☐ورقة علمية / Research Paper
☐تقرير علمي / Scientific Report
☐أبحاث طبية / Medical Research
☐أخرى / Other
9. وصف مختصر للبحث
Brief Description of Research
Diabetes is a chronic metabolic disease associated with significant morbidity, mortality, and global health expenditure; attributable for 966 billion USD per year [1]. In 2021, it was estimated that 529 million people worldwide lived with diabetes, a 6.1 % global prevalence [2], expected to increase to 12.2 % by 2045. Whilst the incidence of both type 1 (T1D) and type 2 diabetes (T2D) have increased, T2D accounts for up to 96 % of all cases [2]. There is a major burden of macrovascular and micro-vascular complications in diabetes: ischaemic heart disease, cerebral infarction, heart failure and peripheral vascular disease (macrovascular) and diabetic retinopathy, nephropathy and neuropathy (microvascular disease) [3]. T2D is a leading cause of chronic kidney disease (CKD) [4] and non-traumatic lower limb amputation [5]; and diabetic retinopathy is one of the leading causes of blindness in working age adults [6,7]. Individuals living with diabetes are twice as likely to die from cardiovascular (CV) disease compared to the general population [8] and younger onset T2D is associated with a disproportionately higher CV risk incidence and prevalence compared to adults diagnosed later [9]. These complications account for the majority of disability and premature deaths among people living with diabetes. Globally, one in nine adults is estimated to have diabetes, and projections suggest the burden will continue to rise until at least 2050 [10].Therefore, to facilitate future resource allocation and health care planning, and target disease prevention, a better understanding of KAP towards diabetes associated complications is required. In Sudan and East Africa, the burden of complications is rising alongside increasing prevalence of diabetes. Hospital‑based tudies in Sudan have reported high rates of retinopathy and neuropathy among diabetic patients, with poor adherence to preventive practices such as regular eye and foot examinations [11]. A study in Ethiopia similarly found that while 65% of patients had positive attitudes toward complication prevention, fewer than half practiced recommended preventive measures, with education and urban residence strongly influencing outcomes [12]. These findings highlight the persistent knowledge‑practice gap in the region, underscoring the need for localized research and interventions. This study in Dongola, Sudan (2026), is therefore timely, aiming to assess the knowledge, attitudes, and preventive practices (KAP) of diabetic patients toward complications, and to identify sociodemographic factors influencing these outcomes

القسم الثالث: الجوانب الأخلاقية / Ethical Considerations

10. طريقة الحصول على الموافقة من المشاركين
Method of Obtaining Consent from Participants
☑مكتوبة / Written
☐شفهية / Verbal
☐غير مطبقة / Not Applicable
☐ضمنية / Implied
☐إعفاء / Waiver
يرجى إرفاق نموذج الموافقة / Please attach consent form
11. آلية الحفاظ على سرية المعلومات
Confidentiality Measures
“We commit to maintaining confidentiality by protecting all information and ensuring it is used only for ethical and scientific purposes, in accordance with accepted guidelines.”
12. مدى المخاطر على المشاركين
Risk Level to Participants
☐لا توجد / None
☑طفيفة / Minor
☐متوسطة / Moderate
☐عالية / High
يرجى توضيح أي مخاطر محتملة وخطة التعامل معها / Please describe any potential risks and mitigation:
-
13. الفوائد المحتملة للمشاركين أو المجتمع
Potential Benefits to Participants or Society
The findings will be valuable for healthcare providers and ultimately enhance the quality of life of diabetic patients in Dongola.
14. هل تشمل الدراسة فئات ضعيفة؟
Does the study involve vulnerable groups?
☐الأطفال / Children
☐النساء الحوامل / Pregnant Women
☐اللاجئون/النازحون / Refugees/Displaced
☐ذوو الإعاقة / People with Disabilities
☐أخرى / Other:

القسم الرابع: قائمة المرفقات المطلوبة / Required Attachments

نسخة من المقترح البحثي الكامل
Full Research Proposal
أدوات جمع البيانات
Data Collection Tools
خطاب تسهيل من الجامعة
University Facilitation Letter

القسم الخامس: الإقرار والتوقيع / Acknowledgment and Signature

أُقر أنا الموقع أدناه بأن جميع المعلومات الواردة في هذه الاستمارة صحيحة وكاملة، وأتعهد بعدم البدء في أي جزء من الدراسة قبل الحصول على الموافقة الأخلاقية الرسمية، والالتزام بجميع الإرشادات والمعايير الأخلاقية المعتمدة من قبل لجنة الموافقة الأخلاقية.
I, the undersigned, acknowledge that all information provided in this form is accurate and complete, and I agree not to begin any part of the study before receiving official ethical approval, and to comply with all ethical guidelines and standards approved by the Ethical Approval Committee.
اسم الباحث الرئيسي / Principal Investigator Name
سمية فياض مدني محمد
التوقيع / Signature
_______________________
التاريخ / Date
2026-01-12

معلومات الباحث / Researcher Information

�

سمية فياض مدني محمد

Semsema9720@gmail.com

0929120457

�

فجر عماد محمد علي

Fajrmad11@gmail.com

0127932399

�

هبة زين الدين فضل سعد

Hibazain789@gmail.com

0117805492

�

هند سليمان عبد الرحمن عمر

hindoya.ansari@gmail.com

091 037 3258

مركز السكري

اسم المؤسسة التي سيتم فيها عمل البحث / Name of the institution where the research will be conducted

Sheikh Abdulaziz bin Abdullah Al Jameih Centre for Diabetes Diseases and Surgery

معلومات الدراسة / Study Information

بكالوريوس / Bachelor's

بكالوريوس - Bachelor

0.00 SDG

Diabetes is a chronic metabolic disease associated with significant morbidity, mortality, and global health expenditure; attributable for 966 billion USD per year [1]. In 2021, it was estimated that 529 million people worldwide lived with diabetes, a 6.1 % global prevalence [2], expected to increase to 12.2 % by 2045. Whilst the incidence of both type 1 (T1D) and type 2 diabetes (T2D) have increased, T2D accounts for up to 96 % of all cases [2]. There is a major burden of macrovascular and micro-vascular complications in diabetes: ischaemic heart disease, cerebral infarction, heart failure and peripheral vascular disease (macrovascular) and diabetic retinopathy, nephropathy and neuropathy (microvascular disease) [3]. T2D is a leading cause of chronic kidney disease (CKD) [4] and non-traumatic lower limb amputation [5]; and diabetic retinopathy is one of the leading causes of blindness in working age adults [6,7]. Individuals living with diabetes are twice as likely to die from cardiovascular (CV) disease compared to the general population [8] and younger onset T2D is associated with a disproportionately higher CV risk incidence and prevalence compared to adults diagnosed later [9]. These complications account for the majority of disability and premature deaths among people living with diabetes. Globally, one in nine adults is estimated to have diabetes, and projections suggest the burden will continue to rise until at least 2050 [10].Therefore, to facilitate future resource allocation and health care planning, and target disease prevention, a better understanding of KAP towards diabetes associated complications is required. In Sudan and East Africa, the burden of complications is rising alongside increasing prevalence of diabetes. Hospital‑based tudies in Sudan have reported high rates of retinopathy and neuropathy among diabetic patients, with poor adherence to preventive practices such as regular eye and foot examinations [11]. A study in Ethiopia similarly found that while 65% of patients had positive attitudes toward complication prevention, fewer than half practiced recommended preventive measures, with education and urban residence strongly influencing outcomes [12]. These findings highlight the persistent knowledge‑practice gap in the region, underscoring the need for localized research and interventions. This study in Dongola, Sudan (2026), is therefore timely, aiming to assess the knowledge, attitudes, and preventive practices (KAP) of diabetic patients toward complications, and to identify sociodemographic factors influencing these outcomes

Dec 30, 2025 - Feb 28, 2026

Jan 13, 2026 - Jan 28, 2026

الاعتبارات الأخلاقية / Ethical Considerations

Written

مخاطر منخفضة - Low Risk

“We commit to maintaining confidentiality by protecting all information and ensuring it is used only for ethical and scientific purposes, in accordance with accepted guidelines.”

The findings will be valuable for healthcare providers and ultimately enhance the quality of life of diabetic patients in Dongola.